Invesaro

Stocks Health care HSTC

OTC · Health care

HST Global, Inc. (HSTC)

HST Global, Inc. brought in $0 of revenue over the twelve months to September 30, 2024. It posted a net loss of $101.5K. At September 30, 2024 it held $10.4K in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on November 3, 2025.

Watch HSTC in 60 seconds
Price
$0.70
+7.69% on the day · September 25, 2026
52-week range $0.00 to $1.05
Market cap
$29.9M
Revenue (last 12 months)
$0

What HST Global, Inc. does

HST Global, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker HSTC.

Revenue and profit by year

Revenue
FY17: $0 $0 FY17FY18: $0 $0 FY18FY19: $0 $0 FY19FY20: $0 $0 FY20FY21: $0 $0 FY21FY22: $0 $0 FY22FY23: $0 $0 FY23
Net income
FY16: -$173K -$173K FY16FY17: -$165.1K -$165.1K FY17FY18: -$178.3K -$178.3K FY18FY19: $426.6K $426.6K FY19FY20: -$209K -$209K FY20FY21: -$148.4K -$148.4K FY21FY22: -$145.1K -$145.1K FY22FY23: -$146.2K -$146.2K FY23

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2023$0-$140.9K-$146.2K-$0.03n/a
2022$0-$141K-$145.1K-$0.03n/a
2021$0-$145.7K-$148.4K-$0.03n/a
2020$0-$208K-$209K-$0.04n/a
2019$0-$151.6K$426.6K$0.13n/a
2018$0-$142.6K-$178.3K-$0.07n/a

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What HST Global, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. July 23, 2026
  2. November 10, 2025
  3. November 3, 2025
  4. November 3, 2025
    Annual report 10-K · period to December 31, 2024
  5. April 2, 2025
  6. March 31, 2025
  7. March 20, 2025
  8. November 22, 2024
    Quarterly report 10-Q · period to September 30, 2024Diluted EPS $0.00 versus -$0.01.
  9. November 15, 2024
  10. November 12, 2024

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 16, 2024. Insider transactions on SEC

Who owns HSTC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Field Michael L13D, may seek influence 31% 86,883,146 July 23, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HSTC

What does HST Global, Inc. do?

HST Global, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker HSTC.

Is HST Global, Inc. profitable?

No. Over the twelve months to September 30, 2024 it reported a net loss of $101.5K.

How much revenue does HST Global, Inc. make?

Over the twelve months to September 30, 2024 HST Global, Inc. reported revenue of $0.

When did HST Global, Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on November 3, 2025. It covers the period to December 31, 2024. Its newest filing of any kind is the activist stake (5% or more) from July 23, 2026.

Similar companies

Compare HSTC with

Compare HSTC with any company

Follow HSTC

Get an email when HST Global, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow HSTC: get an email when it files

Where the numbers come from

Financial figures are the values HST Global, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.